You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues

Authors

  1. Correspondence to Dr David Y Graham, Department of Medicine, Baylor College of Medicine and Michael E DeBakey Veterans Affairs Medical Center, RM 3A-318B (111D), 2002 Holcombe Boulevard, Houston, TX 77030, USA; dgraham{at}bcm.edu
View Full Text

Citation

Graham DY
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues
Gut 2017;66:384-386.

Publication history

  • Received March 4, 2016
  • Revised March 14, 2016
  • Accepted March 21, 2016
  • First published April 7, 2016.
Online issue publication 
January 06, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/